The influence of ageing in the cerebrospinal fluid concentrations of proteins that are derived from the choroid plexus, brain, and plasma

Experimental Gerontology

Volumn 47, Issue 4, 2012, Pages 323-328

  Chen, Carl P C ^a,b   Chen, Ruo Li ^b   Preston, Jane E ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ageing; Albumin; Blood brain barrier; Cerebrospinal fluid; Choroid plexus; Protein; Ratio; Turnover

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; APOLIPOPROTEIN A1; GELSOLIN; LACTOFERRIN; PREALBUMIN; RETINOL BINDING PROTEIN;

AGE DISTRIBUTION; AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CALCULATION; CHOROID PLEXUS; CONTROLLED STUDY; FEMALE; HUMAN; MEASUREMENT; MIDDLE AGED; MOLECULAR WEIGHT; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION;

AGING; ANIMALS; BLOOD PROTEINS; BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID PROTEINS; CHOROID PLEXUS; FEMALE; PROTEOMICS; SHEEP;

EID: 84862782622     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2012.01.008     Document Type: Article

References (21)

1. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 2004, 104:29-45.
2. Bohrmann B., Tjernberg L., Kuner P., Poli S., Levet-Trafit B., Naslund J., Richards G., Huber W., Dobeli H., Nordstedt C. Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 1999, 274:15990-15995.
3. Chen R.L., Athauda S.B., Kassem N.A., Zhang Y., Segal M.B., Preston J.E. Decrease of transthyretin synthesis at the blood-cerebrospinal fluid barrier of old sheep. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:852-858.
4. Chen R.L., Sage E.A., Dunn M.J., Wait R., Preston J.E. Optimising ovine cerebrospinal fluid preparation for two-dimensional gel electrophoresis. Proteomics 2006, 6:3170-3175.
5. Chen C.P., Chen R.L., Preston J.E. Age-related increase of prostaglandin D(2) synthase concentration and glycation in ovine cerebrospinal fluid. Exp. Gerontol. 2009, 44:639-645.
6. Chen R.L., Kassem N.A., Redzic Z.B., Chen C.P., Segal M.B., Preston J.E. Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep. Exp. Gerontol. 2009, 44:289-296.
7. Chen C.P., Chen R.L., Preston J.E. The influence of cerebrospinal fluid turnover on age-related changes in cerebrospinal fluid protein concentrations. Neurosci. Lett. 2010, 476:138-141.
8. Davson H., Segal M.B. Physiology of the CSF and blood-brain barriers 1996, CRC Press, Inc, Florida.
9. Garton M.J., Keir G., Lakshmi M.V., Thompson E.J. Age-related changes in cerebrospinal fluid protein concentrations. J. Neurol. Sci. 1991, 104:74-80.
10. Johanson C.E., Duncan J.A., Klinge P.M., Brinker T., Stopa E.G., Silverberg G.D. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal fluid Res. 2008, 5:10.
11. Nelson P.T., Saper C.B. Ultrastructure of neurofibrillary tangles in the cerebral cortex of sheep. Neurobiol. Aging 1995, 16:315-323.
12. Preston J.E., Segal M.B. The steady-state amino acid fluxes across the perfused choroid plexus of the sheep. Brain Res. 1990, 525:275-279.
13. Reiber H. Flow rate of cerebrospinal fluid (CSF) - a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 1994, 122:189-203.
14. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor. Neurol. Neurosci. 2003, 21:79-96.
15. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 2001, 184:101-122.
16. Schipper H.M. Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann. N. Y. Acad. Sci. 2004, 1012:84-93.
17. Serot J.M., Christmann D., Dubost T., Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1997, 63:506-508.
18. Summerfield S.G., Read K., Begley D.J., Obradovic T., Hidalgo I.J., Coggon S., Lewis A.V., Porter R.A., Jeffrey P. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J. Pharmacol. Exp. Ther. 2007, 322:205-213.
19. Terazaki H., Ando Y., Nakamura M., Obayashi K., Misumi S., Shoji S., Yamashita S., Nakagawa K., Ishizaki T., Suhr O., Uemoto S., Inomata Y., Tanaka K. Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation. Transplantation 2001, 72:296-299.
20. Tumani H., Nau R., Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann. Neurol. 1998, 44:882-889.
21. Wait R., Gianazza E., Eberini I., Sironi L., Dunn M.J., Gemeiner M., Miller I. Proteins of rat serum, urine, and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison. Electrophoresis 2001, 22:3043-3052.